North America Analgesics Market Report by Type (Prescription Analgesics, OTC Analgesics), Drug Class (Opioids, NSAID, and Others), Route of Administration (Oral, Parenteral, Topical, Transdermal, Rectal), Pain Type (Musculoskeletal Pain, Surgical and Trau

North America Analgesics Market Report by Type (Prescription Analgesics, OTC Analgesics), Drug Class (Opioids, NSAID, and Others), Route of Administration (Oral, Parenteral, Topical, Transdermal, Rectal), Pain Type (Musculoskeletal Pain, Surgical and Trauma Pain, Cancer Pain, Neuropathic Pain, Migraine, Obstetrical Pain, Fibromyalgia, Pain due to Burns, Dental/Facial Pain, Pediatric Pain, and Others), Application (Internal Analgesics, External Analgesics), and Country 2024-2032

The North America analgesics market size reached US$ 24.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 31.9 Billion by 2032, exhibiting a growth rate (CAGR) of 3% during 2024-2032.

An analgesic or painkiller is any member of the group of drugs used for achieving analgesia or relief from pain. Analgesic drugs act in different ways on the peripheral and central nervous systems. They mostly include paracetamol or acetaminophen, the nonsteroidal anti-inflammatory drugs (NSAIDs), such as the salicylates, and opioid drugs, including morphine and oxycodone. Analgesics are taken to relieve pain that can arise from appendicitis, surgery, infection, headaches, mensuration, cancer, pain syndromes, sprains, strains, toothache, etc.

The North America analgesics market is currently driven by several factors. The rising geriatric population suffering from incurable health issues, such as joint pain, has stimulated the demand for pain treatment therapies. These therapies employ different types of analgesics, thus catalyzing the market growth in the region. Moreover, the prevalence of osteoarthritis, cardiovascular diseases and cancer have substantially risen in the region, which has also induced the demand for analgesics. Furthermore, the growing number of surgeries, coupled with the penetration of effective pain management medications is expected to fuel the growth of the market during the next few years. Apart from this, availability of analgesics drugs in forms of gels, creams, sprays and oral tablets has made them consumer friendly.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the North America analgesics market report, along with forecasts at the regional and country level from 2024-2032. Our report has categorized the market based on type, drug class, route of administration, pain type and application.

Key Regions Analysed
United States
Canada
Mexico

Analysis for Each Country

Market by Type

Prescription Analgesics
OTC Analgesics

Market by Drug Class
Opioids
NSAID
Others

Market by Route of Administration
Oral
Parenteral
Topical
Transdermal
Rectal

Market by Pain Type
Musculoskeletal Pain
Surgical and Trauma Pain
Cancer Pain
Neuropathic Pain
Migraine
Obstetrical Pain
Fibromyalgia
Pain due to Burns
Dental/Facial Pain
Pediatric Pain
Others

Market by Application
Internal Analgesics
External Analgesics

Value Chain Analysis
Key Drivers and Challenges
Porters Five Forces Analysis
PESTEL Analysis
Government Regulations
Competitive Landscape
Competitive Structure
Key Player Profiles

Key Questions Answered in This Report:

How has the North America analgesics market performed so far and how will it perform in the coming years?
What are the key regions in the North America analgesics market?
What has been the impact of COVID-19 on the North America analgesics market?
What is the breakup of the North America analgesics market on the basis of type?
What is the breakup of the North America analgesics market on the basis of drug class?
What is the breakup of the North America analgesics market on the basis of route of administration?
What is the breakup of the North America analgesics market on the basis of pain type?
What is the breakup of the North America analgesics market on the basis of application?
What are the various stages in the value chain of the North America analgesics industry?
What are the key driving factors and challenges in the North America analgesics industry?
What is the structure of the North America analgesics industry and who are the key players?
What is the degree of competition in the North America analgesics industry?
What are the profit margins in the North America analgesics industry?